Federal Register / Vol. 75, No. 176 / Monday, September 13, 2010 / Notices 55583 

initiatives, with respect to minority 

health conditions and other populations 

with health disparities; (2) Plans, 

coordinates, reviews, and evaluates 

research and other activities on minority 

health and health disparities conducted 

or supported by the NIH Institutes and 

Centers (ICs), consistent with the 

NIMHD’s authorizing statute; (3) In 

collaboration with the NIH Director and 

other IC Directors, and in consultation 

with the NIMHD advisory council, 

develops a comprehensive strategic plan 

and budget that identifies and 

establishes priorities, objectives, 

budgets, and policy statements for the 

conduct and support of all NIH minority 

health and health disparities research 

activities, and ensures that all amounts 

appropriated for such activities are 

expended in accordance with the 

strategic plan and budget; (4) In 

collaboration with the NIH Director and 

other IC Directors, and in consultation 

with the NIMHD advisory council, 

promotes coordination and 

collaboration among ICs conducting or 

supporting minority health or other 

health disparities research; (5) Provides 

leadership for a national and 

international program on minority 

health and health disparities research; 

(6) Represents the NIH minority health 

and health disparities research program 

at all relevant Executive Branch task 

forces, committees, and planning 

activities; (7) Develops and maintains a 

Health Disparities Information (HDI) 

database to facilitate the collection of 

data, translation of research, education, 

dissemination, and communication of 

information to various audiences, 

including the Public Health Service 

(PHS) and other Federal agencies, on 

minority health and health disparities 

research, advances, and other activities 

including those planned, conducted, or 

supported by the NIH; (8) Establishes 

projects to promote cooperation among 

Federal agencies, State, local, tribal, and 

regional public health agencies, and 

private entities in health disparities 

research; (9) Develops and revises, as 

necessary, the national definition for 

health disparity population in 

consultation with the Agency for 

Healthcare Research and Quality; (10) 

Provides leadership for the 

implementation of the Minority Health 

and Health Disparities Research and 

Education Act (Pub. L. 106–525) and the 

Patient Protection and Affordable Care 

Act (Pub. L. 111–148) and other relevant 

public laws as they relate to the NIMHD 

mission and the NIH minority health 

and health disparities research and 

activities. 

Delegations of authority statement: 

All delegations and redelegations of 

authority to officers and employees of 

NIH that were in effect immediately 

prior to the effective date of this 

reorganization and are consistent with 

this reorganization shall continue in 

effect, pending further redelegation. 

Dated: August 4, 2010. 

Kathleen Sebelius, 

Secretary. 

[FR Doc. 2010–22666 Filed 9–10–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Proposed Collection: 

Comment Request 

In compliance with the requirement 

for opportunity for public comment on 

proposed data collection projects 

(section 3506(c)(2)(A) of Title 44, United 

States Code, as amended by the 

Paperwork Reduction Act of 1995, Pub. 

L. 104–13), the Health Resources and 

Services Administration (HRSA) 

publishes periodic summaries of 

proposed projects being developed for 

submission to the Office of Management 

and Budget (OMB), under the 

Paperwork Reduction Act of 1995. To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and draft 

instruments, e-mail 

paperwork@hrsa.gov or call the HRSA 

Reports Clearance Officer at (301) 443– 

1129. 

Comments are invited on: (a) The 

proposed collection of information for 

the proper performance of the functions 

of the agency; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. 

Proposed Project: Ryan White HIV/ 

AIDS Program Core Medical Services 

Waiver Application Requirements 

(OMB No. 0915–0307)—Extension 

Title XXVI of the Public Health 

Service (PHS) Act, as amended by the 

Ryan White HIV/AIDS Treatment 

Extension Act of 2009, (Ryan White 

HIV/AIDS Program), requires that 

grantees expend 75 percent of Parts A, 

B, and C funds on core medical services, 

including antiretroviral drugs, for 

individuals with HIV/AIDS identified 

and eligible under the legislation. In 

order for grantees under Parts A, B, and 

C to be exempted from the 75 percent 

core medical services requirement, they 

must request and receive a waiver from 

HRSA, as required in the Act. 

HRSA utilizes standards for granting 

waivers of the core medical services 

requirement for the Ryan White HIV/ 

AIDS Program. These standards meet 

the intent of the Ryan White HIV/AIDS 

Program to increase access to core 

medical services, including 

antiretroviral drugs, for persons with 

HIV/AIDS and to ensure that grantees 

receiving waivers demonstrate the 

availability of such services for 

individuals with HIV/AIDS identified 

and eligible under Title XXVI of the 

PHS Act. The core medical services 

waiver uniform standard and waiver 

request process will apply to Ryan 

White HIV/AIDS Program Grant awards 

under Parts A, B, and C of Title XXVI 

of the PHS Act. Core medical services 

waivers will be effective for a 1-year 

period that is consistent with the grant 

award period. 

Grantees must submit a waiver 

request with the annual grant 

application containing the certifications 

and documentation which will be 

utilized by HRSA in making 

determinations regarding waiver 

requests. Grantees must provide 

evidence that all of the core medical 

services listed in the statute, regardless 

of whether such services are funded by 

the Ryan White HIV/AIDS Program, are 

available to all individuals with HIV/ 

AIDS identified and eligible under Title 

XXVI of the PHS Act in the service area 

within 30 days. 

The annual estimate of burden is as 

follows: 

Application Number of 

respondents 

Responses per 

respondent 

Total 

responses 

Hours per 

response 

Total burden 

hours 

Waiver request ................................................................. 10 1 10 6.5 60 

mstockstill on DSKB9S0YB1PROD with NOTICES

55584 Federal Register / Vol. 75, No. 176 / Monday, September 13, 2010 / Notices 

Application Number of 

respondents 

Responses per 

respondent 

Total 

responses 

Hours per 

response 

Total burden 

hours 

Total .......................................................................... 10 1 10 6.5 60 

E-mail comments to 

paperwork@hrsa.gov or mail the HRSA 

Reports Clearance Officer, Room 10–33, 

Parklawn Building, 5600 Fishers Lane, 

Rockville, MD 20857. Written comments 

should be received within 60 days of 

this notice. 

Dated: September 3, 2010. 

Sahira Rafiullah, 

Director, Division of Policy and Information 

Coordination. 

[FR Doc. 2010–22662 Filed 9–10–10; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

Periodically, the Health Resources 

and Services Administration (HRSA) 

publishes abstracts of information 

collection requests under review by the 

Office of Management and Budget 

(OMB), in compliance with the 

Paperwork Reduction Act of 1995 (44 

U.S.C. Chapter 35). To request a copy of 

the clearance requests submitted to 

OMB for review, e-mail 

paperwork@hrsa.gov or call the HRSA 

Reports Clearance Office on (301) 443– 

1129. 

The following request has been 

submitted to the Office of Management 

and Budget for review under the 

Paperwork Reduction Act of 1995: 

Proposed Project: Organ Procurement 

and Transplantation Network and 

Scientific Registry of Transplant 

Recipients Data System (OMB No. 

0915–0157)—Extension 

Section 372 of the Public Health 

Service (PHS) Act requires that the 

Secretary, by contract, provide for the 

establishment and operation of an Organ 

Procurement and Transplantation 

Network (OPTN). The OPTN, among 

other responsibilities, operates and 

maintains a national waiting list of 

individuals requiring organ transplants, 

maintains a computerized system for 

matching donor organs with transplant 

candidates on the waiting list, and 

operates a 24-hour system to facilitate 

matching organs with individuals 

included in the list. 

Data for the OPTN data system are 

collected from transplant hospitals, 

organ procurement organizations, and 

tissue-typing laboratories. The 

information is used to indicate the 

disease severity of transplant 

candidates, to monitor compliance of 

member organizations with OPTN rules 

and requirements, and to report 

periodically on the clinical and 

scientific status of organ donation and 

transplantation in this country. Data are 

used to develop transplant, donation 

and allocation policies, to determine if 

institutional members are complying 

with policy, to determine memberspecific performance, to ensure patient 

safety when no alternative sources of 

data exist and to fulfill the requirements 

of the OPTN Final Rule. The practical 

utility of the data collection is further 

enhanced by requirements that the 

OPTN data must be made available, 

consistent with applicable laws, for use 

by OPTN members, the Scientific 

Registry of Transplant Recipients, the 

Department of Health and Human 

Services, and others for evaluation, 

research, patient information, and other 

important purposes. 

No revisions of the 29 data collection 

forms are proposed at this time; 

however, the OPTN is currently 

undergoing a review of the forms and 

expects to submit proposed revisions 

within the next year. 

The annual estimate of burden is as 

follows: 

Form Number of 

respondents 

Responses per 

respondent 

Total 

responses 

Hours per 

response 

Total burden 

hours 

Deceased Donor Registration ...................................... 58 216 12,528 0.7500 9,396.0000 

Death referral data ....................................................... 58 12 696 10.0000 6,960.0000 

Death Notification Referral—Eligible ........................... 58 161 9338 0.2000 1,867.6000 

Death Notification Referral—Imminent ........................ 58 168 9744 0.5000 4,872.0000 

Living Donor Registration ............................................ 308 39 12,012 0.6500 7,807.8000 

Living Donor Follow-up ................................................ 308 50 15,400 0.5000 7,700.0000 

Donor Histocompatibility .............................................. 156 131 20,436 0.1000 2,043.6000 

Recipient Histocompatibility ......................................... 156 196 30,576 0.2000 6,115.2000 

Heart Candidate Registration ...................................... 127 35 4,445 0.5000 2,222.5000 

Lung Candidate Registration ....................................... 68 42 2,856 0.5000 1,428.0000 

Heart/Lung Candidate Registration ............................. 51 2 102 0.5000 51.0000 

Thoracic Registration ................................................... 127 36 4,572 0.7500 3,429.0000 

Thoracic Follow-up ....................................................... 127 320 40,640 0.6500 26,416.0000 

Kidney Candidate Registration .................................... 241 183 44,103 0.5000 22,051.5000 

Kidney Registration ...................................................... 241 83 20,003 0.7500 15,002.2500 

Kidney Follow-up* ........................................................ 241 742 178,822 0.5500 98,352.1000 

Liver Candidate Registration ....................................... 129 109 14,061 0.5000 7,030.5000 

Liver Registration ......................................................... 129 58 7,482 0.6500 4,863.3000 

Liver Follow-up ............................................................. 129 519 66,951 0.5000 33,475.5000 

Kidney/Pancreas Candidate Registration .................... 143 14 2,002 0.5000 1,001.0000 

Kidney/Pancreas Registration ...................................... 143 7 1,001 0.9000 900.9000 

Kidney/Pancreas Follow-up ......................................... 143 85 12,155 0.8500 10,331.7500 

Pancreas Candidate Registration ................................ 143 7 1,001 0.5000 500.5000 

Pancreas Registration .................................................. 143 3 429 0.7500 321.7500 

Pancreas Follow-up ..................................................... 143 20 2,860 0.6500 1,859.0000 

Intestine Candidate Registration .................................. 44 7 308 0.5000 154.0000 

Intestine Registration ................................................... 44 5 220 0.9000 198.0000 

Intestine Follow-up ....................................................... 44 28 1,232 0.8500 1,047.2000 

mstockstill on DSKB9S0YB1PROD with NOTICES